(ATDN) Herpesvirus treatment for KS

(ATDN) Herpesvirus treatment for KS

Treatment Review No. 20; November 1995

Foscarnet is currently approved for the treatment of a herpesvirus infection called CMV. Because research has connected a type of herpesvirus to this cancer, foscarnet is now being studied as a treatment for KS. In a recent issue of Treatment Review, we mentioned the possibility that the drug acyclovir, commonly and safely used for treating herpesviruses, may be useful for treating KS if it was actually caused by a herpesvirus. This doesn't appear to be the case, although the same study that determined this suggests that two herpesvirus drugs, foscarnet or ganciclovir, may be helpful. Eligibility for this foscarnet study is limited to participants with early KS. Participants will have had KS for no longer than six months and will have received no prior treatment for KS. To apply for either of the studies described above call NYU Medical Center at (212) 263-6565, or The Network at (800) 734-7104.

951101
ATR02006

Always watch for outdated information. This article first appeard in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1995 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1995. AEGIS.